alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from IDS Managed
Futures II, L.P. for the third quarter of 1996 and is qualified in its entirety
by reference to such 10-Q.
</LEGEND>
<CIK> 0000813831
<NAME> IDS MANAGED FUTURES II, L.P.
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1996
<CASH>                                      11,015,830
<SECURITIES>                                         0
<RECEIVABLES>                                   34,031
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            11,049,861
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              11,049,861
<CURRENT-LIABILITIES>                          201,586
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                  10,848,275
<TOTAL-LIABILITY-AND-EQUITY>                11,049,861
<SALES>                                              0
<TOTAL-REVENUES>                               527,699
<CGS>                                                0
<TOTAL-COSTS>                                  272,878
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                254,821
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            254,821
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   254,821
<EPS-PRIMARY>                                    11.97
<EPS-DILUTED>                                    11.97
        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).

The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than March 17, 2010.

**A. Federal Reserve Bank of Atlanta**                     (Steve Foley, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309:                

*1. Anthony Jennings Roy, III*, Marksville, Louisiana; to retain voting shares of Mansura Bancshares, Inc., Mansura, Louisiana, and thereby indirectly retain voting shares of The Cottonport Bank, Cottonport, Louisiana.                

Board of Governors of the Federal Reserve System, February 25, 2010.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. 2010-4225 Filed 3-1-10; 8:45 am]

BILLING CODE 6210-01-S
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1280 Estrone test system. ( a ) *Identification.* An estrone test system is a device intended to measure estrone, an estrogenic steroid, in plasma. Estrone measurements are used in the diagnosis and treatment of numerous disorders, including infertility, amenorrhea, differentiation of primary and secondary ovarian malfunction, estrogen secreting testicular and ovarian tumors, and precocious puberty in females.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2306, Jan. 14, 2000]
O O O O CH 3
11 TH COURT OF APPEALS

EASTLAND

, TEXAS

JUDGMENT

In the matter of Craig White

, * From the 132nd District Cour t

a vexatious litigant, of Scurry County,

Trial Court No. 1

- 2022

No. 11

- 22

- 00 077

- C V * May 19, 2022

* Per Curiam Memorandum Opinio n

(P anel consists of: Bailey , C.J.,

Trotter , J. , and W illiams, J.)

This court has inspected the record in this cause and concludes tha t the appeal

should be dismissed for want of jurisdiction. Therefore, in accordance with this

court’s opinion, the appeal is dismissed. The costs incurred by reason of this

appeal are taxed against Crai g White

.
#### People of the State of Illinois, Plaintiff-Appellee, v. Jeroid Barbour, Sr., a/k/a “Pee Wee” Barbour, Impleaded, Defendant-Appellant.

Gen. No. 10,968. (Abstract of Decision.)

Fourth District.

May 13, 1969.

*335W. H. Hasten, of Springfield, for appellant; Richard A. Hollis, State’s Attorney of Sangamon County, of Springfield (Bruce D. Locher, Assistant State’s Attorney, of counsel), for appellee.

Opinion by

JUSTICE CRAVEN.

Not to be published in full.
§ 524.154 Bacitracin, neomycin, and polymyxin B ophthalmic ointment. ( a ) *Specifications.* Each gram of ointment contains: ( 1 ) 500 units bacitracin, 3.5 milligrams (mg) neomycin sulfate (equivalent to 3.5 mg neomycin base), and 10,000 units polymyxin B sulfate; or
( 2 ) 400 units bacitracin zinc, 5 mg neomycin sulfate (equivalent to 3.5 mg neomycin base), and 10,000 units polymyxin B sulfate.
( b ) *Sponsors.* See sponsor numbers in § 510.600(c) of this chapter as follows: ( 1 ) No. 054771 for use of product described in paragraph (a)(1) as in paragraph (c) of this section.
( 2 ) Nos. 000061, 043264, and 086189 for use of product described in paragraph (a)(2) as in paragraph (c) of this section.
( c ) *Conditions of use in dogs and cats* — ( 1 ) *Amount.* Apply a thin film over the cornea 3 or 4 times daily.
( 2 ) *Indications for use.* Treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to susceptible organisms.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[57 FR 37333, Aug. 18, 1992, as amended at 61 FR 8873, Mar. 6, 1996; 62 FR 61625, Nov. 19, 1997; 77 FR 64717, Oct. 23, 2012; 79 FR 10967, Feb. 27, 2014; 80 FR 61297, Oct. 13, 2015; 88 FR 84701, Dec. 6, 2023]
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
The schedule contains summary financial information from the balance sheet as of
September 30, 1999 and from the statement of  operations  for  the  nine  months
ended September 30, 1999 and is qualified in its entirety by reference  to  such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-END>                                   SEP-30-1999
<CASH>                                         571,803
<SECURITIES>                                   0
<RECEIVABLES>                                  6,789
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0<F1>
<PP&E>                                         9,757,124
<DEPRECIATION>                                 0<F2>
<TOTAL-ASSETS>                                 10,458,879
<CURRENT-LIABILITIES>                          0<F1>
<BONDS>                                        4,914,670
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     5,319,063
<TOTAL-LIABILITY-AND-EQUITY>                   10,458,879
<SALES>                                        1,460,339
<TOTAL-REVENUES>                               1,477,941
<CGS>                                          0
<TOTAL-COSTS>                                  1,148,659
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             286,203
<INCOME-PRETAX>                                43,079
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            43,079
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   43,079
<EPS-BASIC>                                  0
<EPS-DILUTED>                                  0
<FN>
<F1> THE PARTNERSHIP HAS AN UNCLASSIFIED BALANCE SHEET, THEREFORE THE BALANCE IS
$0.
<F2> THIS INFORMATION IS NOT DISCLOSED IN THE PARTNERSHIP'S FORM 10-Q FILING.
</FN>



</TABLE>
Presidential Documents

8793 

Federal Register 

Vol. 75, No. 37 

Thursday, February 25, 2010 

Title 3— 

The President 

Notice of February 23, 2010 

Continuation of the National Emergency Relating to Cuba 

and of the Emergency Authority Relating to the Regulation 

of the Anchorage and Movement of Vessels 

On March 1, 1996, by Proclamation 6867, a national emergency was declared 

to address the disturbance or threatened disturbance of international relations 

caused by the February 24, 1996, destruction by the Cuban government 

of two unarmed U.S.-registered civilian aircraft in international airspace 

north of Cuba. On February 26, 2004, by Proclamation 7757, the national 

emergency was extended and its scope was expanded to deny monetary 

and material support to the Cuban government. The Cuban government 

has not demonstrated that it will refrain from the use of excessive force 

against U.S. vessels or aircraft that may engage in memorial activities or 

peaceful protest north of Cuba. And the unauthorized entry of any U.S.- 

registered vessel into Cuban territorial waters continues to be detrimental 

to the foreign policy of the United States. Therefore, in accordance with 

section 202(d) of the National Emergencies Act (50 U.S.C. 1622(d)), I am 

continuing the national emergency with respect to Cuba and the emergency 

authority relating to the regulation of the anchorage and movement of vessels 

set out in Proclamation 6867 as amended by Proclamation 7757. 

This notice shall be published in the Federal Register and transmitted to 

the Congress. 

THE WHITE HOUSE, 

February 23, 2010. [FR Doc. 2010–4107 

Filed 2–24–10; 11:15 am] 

Billing code 3195–W0–P 


jlentini on DSKJ8SOYB1PROD with FRO0OB#1.EPS</GPH>
# C_2015398EN.01005001.xml

| 30.11.2015 | EN | Official Journal of the European Union | C 398/50 |
| --- | --- | --- | --- |

30.11.2015

EN

Official Journal of the European Union

C 398/50

---

Judgment of the General Court of 7 October 2015 — The Smiley Company v OHIM (Shape of a face in the form of a star)

(Case T-244/14) (1)

1

((Community trade mark - Application for a three-dimensional Community trade mark - Shape of a face in the form of a star - Absolute ground for refusal - Distinctive character - Article 7(1)(b) of Regulation (EC) No 207/2009))

(2015/C 398/63)

Language of the case: English

Parties

Parties

Applicant: The Smiley Company SPRL (Brussels, Belgium) (represented by: A. Freitag and C. Albrecht, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: P. Geroulakos and A. Folliard-Monguiral, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 16 January 2014 (Case R 838/2013-1) concerning an application for registration as a Community trade mark of a three-dimensional sign comprising the shape of a face in the form of a star.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Annuls the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 16 January 2014 (Case R 838/2013-1) with regard to the refusal to register the mark applied for in respect of ‘preserved, frozen, dried and cooked fruits and vegetables; milk products’; |
| --- | --- |

1.

Annuls the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 16 January 2014 (Case R 838/2013-1) with regard to the refusal to register the mark applied for in respect of ‘preserved, frozen, dried and cooked fruits and vegetables; milk products’;

| 2. | Dismisses the action as to the remainder; |
| --- | --- |

2.

Dismisses the action as to the remainder;

| 3. | Orders the parties to bear their own costs. |
| --- | --- |

3.

Orders the parties to bear their own costs.

---

(1)  OJ C 282, 25.8.2014.

1

---
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1330 Globulin test system. ( a ) *Identification.* A globulin test system is a device intended to measure globulins (proteins) in plasma and serum. Measurements of globulin are used in the diagnosis and treatment of patients with numerous illnesses including severe liver and renal disease, multiple myeloma, and other disorders of blood globulins.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2306, Jan. 14, 2000]
§ 830.60 Relabeling of a device that is required to bear a unique device identifier. If you relabel a device that is required to bear a unique device identifier (UDI), you must: ( a ) Assign a new device identifier to the device, and
( b ) Keep a record showing the relationship of the prior device identifier to your new device identifier.
[78 FR 58825, Sept. 24, 2013]
# C_2016211EN.01004701.xml

| 13.6.2016 | EN | Official Journal of the European Union | C 211/47 |
| --- | --- | --- | --- |

13.6.2016

EN

Official Journal of the European Union

C 211/47

---

Judgment of the General Court of 28 April 2016 — Fon Wireless v EUIPO — Henniger (Neofon)

(Case T-777/14) (1)

((EU trade mark - Opposition proceedings - Application for EU word mark Neofon - Earlier national word mark FON - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

(2016/C 211/58)

Language of the case: German

Parties

Applicant: Fon Wireless Ltd (London, United Kingdom) (represented by: J.-B. Devaureix and L. Montoya Terán, lawyers)

Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Andreas Henniger (Starnberg, Germany) (represented by: T. von Groll-Schacht, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 15 September 2014 (Case R 2519/2013-4), relating to opposition proceedings between Fon Wireless Ltd and Andreas Henniger.

Operative part of the judgment

The Court:

| 1. | Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 15 September 2014 (Case R 2519/2013-4); |
| --- | --- |

1.

Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 15 September 2014 (Case R 2519/2013-4);

| 2. | Orders EUIPO to bear its own costs and to pay those incurred by Fon Wireless Ltd; |
| --- | --- |

2.

Orders EUIPO to bear its own costs and to pay those incurred by Fon Wireless Ltd;

| 3. | Orders Andreas Henniger to bear his own costs. |
| --- | --- |

3.

Orders Andreas Henniger to bear his own costs.

---

(1)  OJ C 26, 26.1.2015.

---
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.2162 Bismuth oxychloride. ( a ) *Identity and specifications.* ( 1 ) The color additive bismuth oxychloride shall conform in identity and specifications to the requirements of § 73.1162(a)(1) and (b).
( 2 ) Color additive mixtures of bismuth oxychloride may contain the following diluents: ( i ) For coloring cosmetics generally, only those diluents listed under § 73.1001(a)(1);
( ii ) For coloring externally applied cosmetics, only those diluents listed in § 73.1001(b) and, in addition, nitrocellulose.
( b ) *Uses and restrictions.* The color additive bismuth oxychloride may be safely used in coloring cosmetics generally, including cosmetics intended for use in the area of the eye, in amounts consistent with good manufacturing practice.
( c ) *Labeling.* The color additive and any mixture prepared therefrom intended solely or in part for coloring purposes shall bear, in addition to any information required by law, labeling in accordance with the provisions of § 70.25 of this chapter.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from certification pursuant to section 721(c) of the act.
[42 FR 52394, Sept. 30, 1977]
§ 82.1306 D&C Red No. 6. ( a ) The color additive D&C Red No. 6 shall conform in identity and specifications to the requirements of § 74.1306 (a)(1) and (b) of this chapter.
( b ) The color additive D&C Red No. 6 may be safely used for coloring drugs such that the combined total of D&C Red No. 6 and D&C Red No. 7 does not exceed 5 milligrams per daily dose of the drug.
[47 FR 57691, Dec. 28, 1982]
I

SECTFON 27 - ART1CULATt MATTER FROM RESS *F€- WEIGHT RATE

For purposes of thm Rgulatton, the total process

weight from a stH. process units at a plant

or premises shall * used for determining the

maximum allowable emission of particulate matter.

The process weight rate shall be the equipment

manufacturer’s or designer’s quaranteed maximum

input, whichever isgreater. Where the nature

of any process or operation or the design of any

equipment is such as to permit more thaii one inter

pretation of this definition, the interpretation

that results in the minimum value for allowable

emission shall apply.

27.2 No person may discharge in any one hour, from any

source with process weight En the following range,

dust or fumes from a stack or stacks in total

quantities In excess of the amount shown in the

following table. CTabie 27—li

27.3 For the purpose of establishing allowable emission

limits for approval of new or modifled sources of

particulate matter the values of Table 27-1 can be

used in absence of more stringent emission limits.

27.4 Where the process weight per hour falls between

figures in the left—hand column the exact weight

of permitted discharge may be interpolated.
q17/91

TABLE 27-1

25

50

1 00

150

200

250

300

350

1.00

450

500

550

600

650

700

750

800

850

900

1000

1500

2000

3000

14000

5000

6000

7000

8000

9000

1 0000

20000

27300

PROCESS

WT/HR( 55)

(110)

(220)

(330).

(1.40)

(550)

(660)

(770)

(880)

(990)

(.1 1oo)

(1210)

(1320)

(1430)

(114o)

(1650)

(1760)

(1870)

(1980)

(2200)

(3300)

(41.oo)

(6600)

(8800)

11000)

13200)

15400)

17600)

19800)

22000)

1+4000)

60000)

.12

.23

--5—0.43

.%45—Q. 58

.73

.86

.97

1.08

1.17

1.26

1.35 1 .1.2 1 . 50

1.56

1.63

1.70

1.75

1.81

1.87

1.97

2.44

2.83

3.54

4.20

4.83

5.1.6

6.08

6.70

7.30

4i3.4- 8.10

13.95

18.18

(.26) C .5) 44-,.34 (.94)

(1.60)

(1.89)

(2.14)

(2.38)

(2.58)

(2.78)

(2.97)

(3 .1 3)

(3.29)

(3.41.)

(3.59)

(3.73)

(3.86)

(3.99)

(4.12)

(4.34)

(5.36)

(6

. 22)

(7.78)

(9.23)

(10.63)

(12.01)

(13.37)

(14.73)

(16.07)

cza..,.2_5.) (17.81)

(30.70)

(40.00)

KG (ibs)

MAXIMUM WEIGHT

DISCHARGE/HOUR

KG (ibs)

Or More
# C_2017006EN.01003301.xml

| 9.1.2017 | EN | Official Journal of the European Union | C 6/33 |
| --- | --- | --- | --- |

9.1.2017

EN

Official Journal of the European Union

C 6/33

---

Judgment of the General Court of 9 November 2016 — Birkenstock Sales v EUIPO (representing a pattern of wavy, crisscrossing lines)

(Case T-579/14) (1)

1

((EU trade mark - International registration designating the European Union - Figurative mark representing a pattern of wavy, crisscrossing lines - Absolute ground for refusal - Distinctive character - Article 7(1)(b) of Regulation (EC) No 207/2009 - Surface pattern - Application of a pattern on the packaging of a product))

(2017/C 006/39)

Language of the case: German

Parties

Parties

Applicant: Birkenstock Sales GmbH (Vettelschoß, Germany) (represented by: C. Menebröcker and V. Töbelmann, lawyers)

Applicant:

Defendant: European Union Intellectual Property Office (represented by: initially G. Schneider and D. Walicka, and subsequently D. Walicka, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 15 May 2014 (Case R 1952/2013-1), concerning the international registration designating the European Union of the figurative mark representing a pattern of wavy, crisscrossing lines.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Annuls the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 15 May 2014 (Case R 1952/2013-1) in so far as it concerns the following goods: ‘artificial limbs, eyes and teeth’, ‘suture materials; suture materials for operations’ and ‘animal skins, hides’; |
| --- | --- |

1.

Annuls the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 15 May 2014 (Case R 1952/2013-1) in so far as it concerns the following goods: ‘artificial limbs, eyes and teeth’, ‘suture materials; suture materials for operations’ and ‘animal skins, hides’;

| 2. | Dismisses the action as to the remainder; |
| --- | --- |

2.

Dismisses the action as to the remainder;

| 3. | Orders Birkenstock Sales GmbH to bear its own costs and to pay half of those incurred by EUIPO, and EUIPO to bear half of its own costs. |
| --- | --- |

3.

Orders Birkenstock Sales GmbH to bear its own costs and to pay half of those incurred by EUIPO, and EUIPO to bear half of its own costs.

---

(1)  OJ C 351, 6.10.2014.

1

---